Can I abruptly discontinue imipramine?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 11, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Imipramine Should Not Be Stopped Abruptly

No, you should not stop imipramine suddenly—gradual tapering is required to avoid withdrawal symptoms and potential relapse of your underlying condition. 1, 2

Why Tapering Is Necessary

Abrupt discontinuation of tricyclic antidepressants like imipramine can precipitate withdrawal symptoms including:

  • Flu-like syndrome (headache, myalgia, weakness, fatigue) 2
  • Neuropsychiatric symptoms (anxiety, agitation, nervousness, insomnia, jitteriness) 2
  • Sleep disturbances 2
  • Gastrointestinal distress 2
  • Movement disorders (akathisia, parkinsonism) 2
  • Paradoxical behavioral activation or mania 2

These symptoms can occur even after missing a single dose during ongoing therapy 3, and typically appear within 24-48 hours of discontinuation 2.

FDA-Approved Tapering Protocol

The FDA label explicitly states: "Dosage should be tapered off gradually rather than abruptly discontinued; this may reduce the tendency to relapse." 1

Specific Tapering Approach:

  • Reduce doses gradually over days to weeks 4
  • Start with small decrements to assess tolerance 5
  • Monitor closely for withdrawal symptoms versus relapse of depression 2, 4
  • For patients on higher doses (150-300 mg/day), taper to maintenance doses of 50-150 mg/day before further reduction 1

Critical Distinction: Withdrawal vs. Relapse

Withdrawal symptoms appear within 1 week and resolve spontaneously within 1-3 weeks, while relapse of depression develops more slowly (2-6 weeks) and does not improve without treatment 6. This distinction is crucial for determining whether to resume medication or continue tapering 2.

Special Populations

  • Elderly patients and adolescents: Already on lower doses (30-100 mg/day), requiring even more cautious tapering 1
  • Children with enuresis: Taper gradually after therapeutic trial; abrupt discontinuation increases relapse risk 1

Clinical Caveats

  • Never stop abruptly unless there is confirmed diversion or serious medical toxicity 5
  • Withdrawal symptoms from tricyclics are generally less severe than benzodiazepine withdrawal but still require management 7
  • Imipramine and its derivatives (desipramine, clomipramine) are particularly associated with withdrawal reactions 3
  • Some patients who relapse after discontinuation may not respond to subsequent treatment courses 1

References

Research

Withdrawal symptoms during the course of imipramine therapy.

The Journal of clinical psychiatry, 1980

Research

Switching and stopping antidepressants.

Australian prescriber, 2016

Guideline

Citalopram Withdrawal Symptoms

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.